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Abstract
Background:  Obesity has been linked to an increased risk of female infertility. Leptin, an
adipocytokine which is elevated during obesity, may influence gonadal function through modulating
steroidogenesis in granulosa cells.
Methods:  The effect of leptin on progesterone production in simian virus 40 immortalized
granulosa (SVOG) cells was examined by Enzyme linked immunosorbent assay (ELISA). The effect
of leptin on the expression of the steroidogenic enzymes (StAR, P450scc, 3betaHSD) in SVOG cells
was examined by real-time PCR and Western blotting. The mRNA expression of leptin receptor
isoforms in SVOG cells were examined by using PCR. SVOG cells were co-treated with leptin and
specific pharmacological inhibitors to identify the signaling pathways involved in leptin-reduced
progesterone production. Silencing RNA against leptin receptor was used to determine that the
inhibition of leptin on cAMP-induced steroidogenesis acts in a leptin receptor-dependent manner.
Results and Conclusion: In the present study, we investigated the cellular mechanisms
underlying leptin-regulated steroidogenesis in human granulosa cells. We show that leptin inhibits
8-bromo cAMP-stimulated progesterone production in a concentration-dependent manner.
Furthermore, we show that leptin inhibits expression of the cAMP-stimulated steroidogenic acute
regulatory (StAR) protein, the rate limiting de novo protein in progesterone synthesis. Leptin
induces the activation of ERK1/2, p38 and JNK but only the ERK1/2 (PD98059) and p38 (SB203580)
inhibitors attenuate the leptin-induced inhibition of cAMP-stimulated StAR protein expression and
progesterone production. These data suggest that the leptin-induced MAPK signal transduction
pathway interferes with cAMP/PKA-stimulated steroidogenesis in human granulosa cells.
Moreover, siRNA mediated knock-down of the endogenous leptin receptor attenuates the effect
of leptin on cAMP-induced StAR protein expression and progesterone production, suggesting that
the effect of leptin on steroidogenesis in granulosa cells is receptor dependent. In summary, leptin
acts through the MAPK pathway to downregulate cAMP-induced StAR protein expression and
progesterone production in immortalized human granulosa cells. These results suggest a possible
mechanism by which gonadal steroidogenesis could be suppressed in obese women.
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Background
The major function of the female gonad is to differentiate
and release mature oocytes for fertilization and successful
propagation of the species. The follicular maturation, ovu-
lation and corpus luteum function of mammalian ovaries
is regulated by the interaction between gonadotropin
releasing hormone, gonadotropins, ovarian sex steroids
and a variety of peptide hormones [1]. Dysfunction in the
biosynthesis of sex steroid hormones could impair nor-
mal ovarian function or even cause infertility.
Leptin, a key hormone in energy homeostasis and neu-
roendocrine function, has a permissive role in initiating
puberty and is crucial in the pathogenesis of reproductive
dysfunction in several disease states of energy imbalance
[2]. In obesity, there is an expansion of the adipose tissue
with increased leptin production [3]. Accumulating evi-
dence suggests that increased leptin levels contribute to
the pathogenesis of reproductive abnormalities including
infertility, polycystic ovary syndrome (PCOS), anovula-
tion, disruption of the menstrual cycle, hyperinsulinemia
and many other conditions [4-6].
Recent studies that have identified expression of the leptin
receptor in several peripheral tissues (eg. ovary, testis and
adrenal gland) strongly suggest that leptin may have a
direct effect on downstream endocrine targets of the
reproductive axis [7,8]. In vitro studies conducted on the-
cal and granulosa cells have shown that leptin has nega-
tive effects on ovarian steroid output in rodent, bovine
and human models. In particular, it has been found that:
1) Leptin antagonizes insulin action in human granulosa
cells and thereby inhibits their gonadotropin-stimulated
progesterone production [9]; 2) Leptin stimulates the
release of proinflamatory cytokines and prostaglandins in
human placenta [4]; 3) High serum and follicular fluid
leptin may account for decreased fertilization, implanta-
tion and pregnancy rates of IVF in PCOS women [10].
Conditions with abnormally elevated leptin concentra-
tions and impaired ovarian function may be due to dis-
turbed steroidogenesis. However, the mechanisms by
which leptin modulates steroidogenesis in the ovary
remain elusive.
In the present study, we investigated the underlying mech-
anisms through which leptin modulates steroidogenesis
in human granulosa cells. We found that treatment of
immortalized granulosa cells with increasing doses of lep-
tin inhibited 8-bromo cAMP-induced steroidogenesis
with downregulation of the de novo produced steroidog-
enic acute regulatory (StAR) protein. In addition, we dem-
onstrated that cAMP-regulated steroidogenic enzymes and
progesterone production could be inhibited by leptin via
the MAPK pathway.
Methods
Cell culture and chemicals
Studies of human ovarian granulosa cells have been lim-
ited by the small numbers and short life span in culture of
cells currently obtained from clinical material. Using
SV40 large T antigen, we have reproducibly immortalized
freshly explanted human granulosa cells obtained
through an in vitro fertilization program. The use of
immortalized granulosa cells for this study was approved
by the University of British Columbia Research Ethics
Board. This cell line was shown to posses the same ster-
oidogenic capabilities as primary human granulosa cells
[11]. Cells are maintained in growth medium
(M199:MCDB 105 (Sigma-Aldrich Corp., St. Louis, MO)
containing 10% (v/v) fetal bovine serum (FBS; Hyclone
Laborataries Inc., Logan, UT), 100 units/mL penicillin,
100  g/mL streptomycin (Sigma) under a humidified
atmosphere of 5% CO2 at 37°C and changed every 3 days.
For each experiment, 2 × 105 immortalized granulosa cells
were incubated in serum free medium for 4 h prior to
treatment. Human recombinant leptin, 8-bromo cAMP,
and SB203580 were purchased from Sigma. PD98059 and
SP600125 were purchased from Calbiochem (San Diego,
CA).
RNA extraction and semiquantitave PCR
Total RNA was extracted with Trizol reagent (Invitrogen
Inc., Burlington, ON, Canada) according to the manufac-
turer's instructions. Reverse transcription was performed
in a mixture containing 5 M random hexamer, 200 M
dNTP, 2 U/l MMLV trasnscriptase (Promega, Madison,
WI) and 1 g RNA with the corresponding buffer at 42°C
for 90 min followed by 85°C for 10 min. The cDNA was
further amplified by specific primer pairs, including for-
ward long-form leptin receptor (OBRb) (5'-CCA GAA
ACG TTT GAG CAT CT-3') and reverse OBRb (5'-CAA
AAG CAC ACC ACT CTC TC-3'), forward short-form lep-
tin receptor (OBRa) (5'-GAA GGA GTG GGA AAA CCA
AAG-3') and reverse OBRa (5'-CCA CCA TAT GTT AAC
TCT CAG-3'), forward GAPDH (5'-TCC CAT CAC CAT
CTT CCA-3') and reverse GAPDH (5'-CAT CAC GCC ACA
GTT TCC-3').
Real-time PCR
The primers used for SYBR Green real-time RT-PCR were
designed using the Primer Express Software v2.0 (Applied
Biosystems, Foster City, CA). The specific primer pairs
used are forward StAR (5'-AAACTTACGTGGCTACTCAG-
CATC-3') and reverse StAR (5'-GACCTGGTTGATGAT-
GCTCTTG-3'), forward P450scc (5'-
CAGGAGGGGTGGACACGAC-3') and reverse P450scc
(5'-AGGTTGCGTGCCATCTCATAC-3'), forward 3-HSD
(5'-GCCTTCAGACCAGAATTGAGAGA-3') and reverse 3-
HSD (5'-TCCTTCAAGTACAGTCAGCTTGGT-3'), forward
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reverse GAPDH (5'-CGCCCCACTTGATTTTGG-3'). Real-
time PCR was performed using the ABI prism 7000
Sequence 10 Detection System (Applied Biosystems)
equipped with a 96-well optical reaction plate. The reac-
tions were set up with 16.5 l SYBRR Green PCR Master
Mix (Applied Biosystems). All real-time experiments were
run in triplicate and a mean value was used for the deter-
mination of mRNA levels. Negative controls, containing
water instead of sample cDNA, were used in each experi-
ment. Relative quantification of the mRNA levels for StAR,
P450scc and 3-HSD2 in ovarian cancer cells was per-
formed using the comparative CT method with GAPDH as
an internal standard and with the formula 2-Ct.
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoplates were pre-coated with IgG (Calbiochem)
and nonspecific binding sites were blocked with 0.1% (w/
v) BSA buffer. IgG binds to the Fc fragment of the proges-
terone antibody while the Fab fragment is competitively
bound by both biotinylated progesterone (EastCoast Bio,
Inc. North Berwick, ME) and progesterone in the samples.
The biotinylated progesterone interacts with streptavidin-
horseradish peroxidase (SA-HRP) (EastCoast Bio), which
catalyzes the substrate solution composed of 3,3',5,5'-
tetramethylbenzidine (TMB) (Dojindo Inc., Gaithersburg,
MD), to produce a blue-colored solution. The enzyme-
substrate reaction is stopped by the addition of sulphuric
acid (H2SO4) and the solution turns yellow. The intensity
of the yellow color is directly proportional to the amount
of biotinylated peptide-SA-HRP complex but inversely
proportional to the amount of the progesterone in the
samples. A standard curve of progesterone with known
concentrations was established accordingly, and the pro-
gesterone concentrations in the samples were determined
by extrapolation to this standard curve. The intra- and
inter-assay CV of the progesterone assay were 5.6 and
10.2% respectively.
Western blotting
The cells were washed twice with ice-cold PBS and lysed in
RIPA buffer (150 mM NaCl, 50 mM Tris-base (pH 7.5),
1% (v/v) Nonidet P-40, 0.5% (w/v) sodium deoxycholate,
and 0.1% (v/v) SDS). Twenty micrograms of total protein
were run on 12% SDS-PAGE gels and electrotransferred to
a nitrocellulose membrane (Biorad laboratories, Her-
cules, CA). The membrane was immunoblotted using spe-
cific primary antibodies (StAR, P450scc, 3-HSD and -
actin: Santa Cruz Biotechnology Inc., Santa Cruz, CA;
ERK, phosphorylated ERK, JNK, phosphorylated JNK and
p38: Cell Signaling Technology Inc., Danvers, MA; phos-
phorylated p38: Biosource, Invitrogen) at 4°C overnight.
After washing, the membranes were incubated with horse-
radish peroxidase-conjugated secondary antibody for 1 h,
and visualized using the ECL system (GE Healthcare Bio-
Science, Piscataway NJ).
Statistical analysis
ELISA and real-time PCR normalized data are represented
as mean ± S.E.M. of three independent experiments. West-
ern blot normalized data are represented as mean ± S.D.
of three independent experiments. Statistically significant
differences between treatments and controls were deter-
mined by either two-way ANOVA followed by Bonferroni
test (Figure 1 and Figure 2) or one-way ANOVA followed
by Tukey test (Figure 3, 4, 5). Statistical significance was
set at P < 0.05.
Results
Leptin attenuates the 8-bromo cAMP-stimulated 
progesterone production in human granulosa cells
The gonadotropin-stimulated progesterone production in
granulosa and luteal cell is critical for normal uterine
function, establishment and maintenance of pregnancy,
and mammary gland development [1,12]. To gain insight
into the impact of leptin on gonadotropin-stimulated
steroidogenesis, we co-treated 8-bromo cAMP with
increasing concentration of leptin (10 ng/ml, 100 ng/ml,
1000 ng/ml) for 24 h in immortalized human granulosa
cells. Results showed that leptin inhibited the 8-bromo
cAMP-stimulated progesterone production in a concen-
tration-dependant manner, suggesting that leptin inter-
feres with gonadotropin-stimulated progesterone
production in these cells (Figure 1).
Leptin inhibited 8-bromo cAMP-stimulated progesterone  production in human granulosa cells Figure 1
Leptin inhibited 8-bromo cAMP-stimulated proges-
terone production in human granulosa cells. Cells 
were treated with increasing concentrations of leptin (10 ng/
ml - 1000 ng/ml) in the presence or absence of 1 mM 8-
bromo cAMP for 24 h. Media were collected and assayed for 
progesterone production by ELISA. Each data point in the fig-
ure represents the mean ± SEM of three independent exper-
iments. * above the column indicates that those groups differ 
significantly from untreated control (P < 0.05); (ctrl = con-
trol).Reproductive Biology and Endocrinology 2009, 7:115 http://www.rbej.com/content/7/1/115
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Leptin inhibits the 8-bromo cAMP-induced StAR mRNA 
and protein induction in granulosa cells
The regulation of StAR, P450scc enzyme and 3-HSD is
crucial for regulating steroid hormone production in ster-
oidogenic cells [13,14]. Using real-time PCR, we moni-
tored the effect of leptin on these steroidogenic enzymes.
Results showed that leptin inhibited the transcriptional
mRNA level of StAR (Figure 2A), but not P450scc (Figure
2B) or 3-HSD (Figure 2C), in a temporally-defined man-
ner. In concordance with the mRNA regulation, the pro-
tein level of StAR induced by 8-bromo cAMP is
significantly inhibited by the administration of leptin
after 24 h of treatment (Figure 2D).
Activation of ERK1/2 and p38 are involved in the leptin 
regulated 8-bromo cAMP-stimulated StAR protein 
expression and progesterone production
As we have previously shown, immortalized human gran-
ulosa cells only expressed the short form leptin receptor
(Ob-Ra) (Figure 3A) [15]. It is documented that the MAPK
pathway is the dominant signaling pathway downstream
of Ob-Ra [16,17]. Thus, leptin treatment of human gran-
ulosa cells over different time intervals was used to moni-
tor the activation of the MAPK pathway. As shown in our
results, leptin induced the phosphorylation of ERK1/2
(Figure 3B), p38 (Figure 3C) and JNK (Figure 3D) in a
time-dependent manner. To further elucidate the signal-
Leptin inhibited 8-bromo cAMP-stimulated StAR mRNA and protein expression Figure 2
Leptin inhibited 8-bromo cAMP-stimulated StAR mRNA and protein expression. Cells were treated with leptin 
(1000 ng/ml) in the presence or absence of 8-bromo cAMP (1 mM) for different time scale (1, 3, 6, 12, 24 h) and total RNA was 
analyzed with real time RT-PCR to measure the temporal change of StAR mRNA (A), P450scc mRNA (B) and 3-HSD mRNA 
(C) levels with GAPDH as internal standard. Cell lysates from cotreatment of leptin with 8-bromo cAMP for 24 h was sub-
jected to Western blot analysis to monitor the protein levels of StAR, P450scc and 3-HSD (D). The blots are a Western blot-
ting representative data from three independent experiments. Each data point in the figure represents the mean ± SEM of 
three independent experiments. * above the bars in "A" indicate that cotreatment of leptin with cAMP group significantly differ 
from cAMP treated group in the particular time scale (P < 0.05). (ctrl = control).Reproductive Biology and Endocrinology 2009, 7:115 http://www.rbej.com/content/7/1/115
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Leptin induced MAPK pathway in human granulosa cells Figure 3
Leptin induced MAPK pathway in human granulosa 
cells. (A) The expression of leptin receptor in human 
immortalized granulosa cells were monitored by semi-quanti-
tative RT-PCR. Upper bands showed the expression of short 
form leptin receptor (Ob-Ra) in 4 different passages of 
immortalized granulosa cells. Lower band is to detect the 
expression of long form leptin receptor (Ob-Rb) in immor-
talized granulosa cells. GAPDH was used as internal stand-
ard. Cells were treated with leptin (1000 ng/ml) for different 
time scale (5, 15, 30, 60 min) and cell lysates were collected 
and subjected to Western blot analysis to monitor the 
expression of phosphorylated ERK1/2 (B), phosphorylated 
p38 (C) and phosphorylated JNK (D). Total ERK1/2, p38, 
JNK and -actin were detected as internal standard. Upper 
bands are Western blotting representative datas from three 
independent experiments. Lower bars were integrated opti-
cal density (IOD) of target phosphorylated protein expres-
sion with target total protein normalization. Each data point 
in the figure represents the mean ± SD of three independent 
experiments. * above the bars indicates that those groups 
differ significantly from untreated control (P < 0.05). (ctrl = 
control).
Figure 4
Leptin acted through ERK1/2 and p-38 pathways to
modulate steroidogenesis in human granulosa cells.
Cells were treated with leptin (1000 ng/ml) in the
presence or absence of ERK1/2 inhibitor (PD98059,
25  M), p38 inhibitor (SB203580, 10 M) and JNK
inhibitor (SP600125, 25 M) for 24 h. Cell lysates
were collected and subjected to Western blot analy-
sis to monitor the expression of StAR protein (A)
and media were collected and assayed for progester-
one production by ELISA (B). Upper bands in (A) are
Western blotting representative data from three
independent experiments. Lower bars were inte-
grated optical density (IOD) of StAR protein expres-
sion with -actin normalization. Each data point in
(A) represents the mean ± SD of three independent
experiments. Each data point in (B) represents the
mean ± SEM of three independent experiments. *
above the bars indicate that those groups differ sig-
nificantly from untreated control (P < 0.05).Reproductive Biology and Endocrinology 2009, 7:115 http://www.rbej.com/content/7/1/115
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ing pathways involved in the leptin-inhibited steroido-
genesis in human granulosa cells, we used
pharmacological inhibitors to individually block the
ERK1/2, p38 and JNK pathways. The effectiveness of each
inhibitor was tested prior to use in the current experi-
ments (data not shown). Results showed that pretreat-
ment for 30 minutes with the ERK1/2 inhibitor PD98059
or the p38 inhibitor SB203580 prior to co-treatment with
8-bromo cAMP and leptin reversed the inhibition of lep-
tin on 8-bromo cAMP-induced StAR protein expression
(Figure 4A) and progesterone production (Figure 4B) in
granulosa cells. Interestingly, pretreatment with the JNK
inhibitor SP600125 did not inhibit the leptin effect. These
results suggest that the ERK1/2 and p38 MAPK pathways
are necessary for leptin-mediated interference of cAMP-
stimulated steroidogenesis in human granulosa cells.
Leptin modulates steroidogenesis in human granulosa cells 
through the short form leptin receptor (OB-Ra)
To further confirm the role of the leptin receptor in leptin-
modulated steroidogenesis in human granulosa cells, we
used siRNA technology to knockdown the endogenous
expression of the leptin receptor in these cells. The effec-
tiveness of the siRNA was confirmed by Western blot anal-
ysis (Figure 5A). Knockdown of the leptin receptor in
granulosa cells impaired the ability of leptin to inhibit 8-
bromo cAMP-stimulated StAR protein expression (Figure
5B) and progesterone production (Figure 5C). These
results confirm that leptin acts through its receptor on
immortalized human granulosa cells to initiate the MAPK
pathway and downregulate the cAMP-induced steroido-
genesis.
Discussion
Compelling evidence demonstrates a direct inhibitory
action of leptin on steroid hormone secretion. Such effects
have been independently reported by different groups in
the three major steroidogenic tissues, namely the adrenal
gland, the ovary and the testis [18-22]. However, the
mechanisms for such an inhibitory action are only par-
tially characterized, and little attention has been paid to
the molecular events involved in leptin-induced inhibi-
tion of progesterone secretion in granulosa cells. To gain
insight into the mechanisms whereby leptin suppresses
progesterone secretion in vitro, we correlated the hormo-
nal secretory responses to mRNA expression levels of
StAR, P450scc and 3-HSD in cAMP-stimulated immor-
talized human granulosa cells after exposure to high dos-
age of recombinant human leptin. In the present study we
demonstrate that the physiological induction of StAR pro-
tein by cAMP, a rate-limiting step in steroidogenesis in
steroidogenic cells, is significantly reduced by leptin treat-
ment. These results confirm the predominantly inhibitory
effects that leptin exerts on progesterone production in
human granulosa cells. In addition, it was the first dem-
onstration that the leptin short form receptor was
involved in leptin-mediated inhibition of cAMP-stimu-
lated steroidogenesis via the activation of the MAPK sign-
aling pathway.
Leptin was shown to be distributed in the intact ovary and
have distinct changes in its localization during folliculo-
genesis [23]. Study suggested that leptin may be produced
locally and act in autocrine or paracrine way to affect ster-
oidogenesis in the human ovary [23]. During obesity,
both serum and follicular fluid levels of leptin may be as
high as 100 ng/ml [24,25]and our study provides evi-
dence that this high concentration of leptin suppressed
the production of progesterone in granulosa cells. More
importantly, treatment with a 1000 ng/ml of high dosage
leptin also strikingly inhibited the cAMP-induced ster-
oidogenesis in granulosa cells. This is in agreement with
findings in PCOS demonstrating conspicuous occurrence
of leptin in the wall of polycystic follicles, higher local
concentration of leptin independent of the serum level
with hormonal dysregulation in granulosa cells [26]
which may account for the decreased pregnancy rate in
these PCOS women [10].
Several reports have now demonstrated expression of bio-
logically active isoforms of the leptin receptor in the endo-
crine pancreas [27], the ovary [8] and the placenta [28].
Consistent with this widespread expression, leptin can
directly modulate the activity of these glands. Leptin has
been shown to inhibit insulin secretion from pancreatic -
cells [29]. Leptin decreases the production of estradiol
and progesterone from ovarian granulosa cells [30,31], at
least partly via inhibition of the electron transport protein
adrenodoxin [31]. Finally, leptin can modulate the release
of hCG from human trophoblast cells in culture [32]. In
our cell model, it was shown that only the leptin short
form (Ob-Ra) receptor is expressed in the culture system.
Interestingly, using siRNA to knockdown the endogenous
leptin receptor reversed the inhibition of leptin on cAMP-
induced StAR protein expression and progesterone pro-
duction. These results suggest that Ob-Ra is functional in
our culture system and that this leptin receptor isoform
plays a role in the regulation of steroidogenesis in human
granulosa cells.
Leptin receptors are structurally similar to the class I
cytokine receptor family [33]. In humans, the leptin
receptor (OB-R) is produced in several alternatively
spliced forms, designated OB-Ra, OB-Rb, OB-Rc, OB-Re
[34]. Each of these isoforms has an extracellular domain
and a transmembrane domain in common, with a varia-
ble intracellular domain that is characteristic for each of
the isoforms. Based on the variable intracellular domain
the isoforms are classified as short (OB-Ra), long (OB-Rb)
and secreted (OB-Re) leptin receptor. Other than the clas-Reproductive Biology and Endocrinology 2009, 7:115 http://www.rbej.com/content/7/1/115
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sical JAK/STAT signaling pathways [35], leptin may act
through OB-Ra or OB-Rb to trigger the MAPK cascade in
two different ways, i.e. via tyrosine phosphorylation of
JAK2 receptor-associated activation or independently of
receptor phosphorylaton [17,36]. Although the molecules
that are involved in transmitting the leptin signal have not
been completely elucidated, activated MEKs (MAPK/ERK
kinases) phosphorylate ERKs, leading finally to the
expression of specific target genes, such as c-fos and egr-1,
that participate in cell proliferation and differentiation
[37]. The other two members of the MAP kinase family,
p38 MAP kinase and NH2-terminal c-Jun kinase/stress-
activated protein kinase (JNK) have also been shown to be
activated by leptin [38,39].
Many reports have demonstrated the involvement of the
MAPK pathway in steroidogenesis in granulosa cells. Acti-
vation of the MAPK cascade by gonadotropins mediates
down-regulation of steroidogenesis via attenuation of
StAR expression [40]. EGF (epidermal growth factor)
stimulates steroidogenesis of granulosa cells through acti-
vation of the ERK-related MAP kinase pathway [41].
PGF2 (prostaglandin F2)-induced MAPK activation is
associated with modulation of progesterone production
[42]. In the present study, we demonstrated that leptin is
capable of inducing the phosphorylation of ERK, phos-
phorylation of p38 and phosphorylation of JNK. Interest-
ingly, only the ERK and p38 inhibitors were able to
reverse leptin mediated inhibition of StAR protein expres-
sion and progesterone production in granulosa cells. This
suggests that these two MAPK cascades are involved in lep-
tin mediated inhibition of steroidogenesis in granulosa
cells.
Conclusion
In conclusion, we demonstrate that the StAR protein par-
ticipates in the physiological inhibition of granulosa cells
function by leptin. This leptin-dependent fine tuning of
ovarian function could be of clinical relevance in obesity
and related disorders as well as in the pathogenesis of
infertility.
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